In most species, the meiotic cell cycle is arrested at the transition between prophase and metaphase through unclear somatic signals. Activation of the Cdc2-kinase component of maturation promoting factor (MPF) triggers germinal vesicle breakdown after the luteinizing hormone (LH) surge and reentry into the meiotic cell cycle [1-3]. Although high levels of cAMP and activation of protein kinase A (PKA) play a critical role in maintaining an inactive Cdc2 [4-6], the steps downstream of PKA in the oocyte remain unknown. Using a small-pool expression-screening strategy, we have isolated several putative PKA substrates from a mouse oocyte cDNA library. One of these clones encodes a Wee1-like kinase that prevents progesteroneinduced oocyte maturation when expressed in Xenopus oocytes. Unlike the widely expressed Wee1 and Myt1, mWee1B mRNA and its protein are expressed only in oocytes, and mRNA downregulation by RNAi injection in vitro or transgenic overexpression of RNAi in vivo causes a leaky meiotic arrest. Ser15 residue of mWee1B is the major PKA phosphorylation site in vitro, and the inhibitory effects of the kinase are enhanced when this residue is phosphorylated. Thus, mWee1B is a key MPF inhibitory kinase in mouse oocytes, functions downstream of PKA, and is required for maintaining meiotic arrest. Figure 1A ). Similar to Xenopus Wee1, which prevents progesterone-induced germinal vesicle breakdown (GVBD) by directly phosphorylating and inhibiting Cdc2 kinase [8, 9], ectopically expressed mWee1B also prevented Xenopus oocyte GVBD induced by progesterone treatment in a manner dependent on mRNA concentration Figure 1B) . In addition, the Cdc2 inhibitory phosphorylation (phosphotyrosine 15) was not decreased by progesterone treatment when mWee1B mRNA was overexpressed ( Figure 1C) .
In most species, the meiotic cell cycle is arrested at the transition between prophase and metaphase through unclear somatic signals. Activation of the Cdc2-kinase component of maturation promoting factor (MPF) triggers germinal vesicle breakdown after the luteinizing hormone (LH) surge and reentry into the meiotic cell cycle [1] [2] [3] . Although high levels of cAMP and activation of protein kinase A (PKA) play a critical role in maintaining an inactive Cdc2 [4] [5] [6] , the steps downstream of PKA in the oocyte remain unknown. Using a small-pool expression-screening strategy, we have isolated several putative PKA substrates from a mouse oocyte cDNA library. One of these clones encodes a Wee1-like kinase that prevents progesteroneinduced oocyte maturation when expressed in Xenopus oocytes. Unlike the widely expressed Wee1 and Myt1, mWee1B mRNA and its protein are expressed only in oocytes, and mRNA downregulation by RNAi injection in vitro or transgenic overexpression of RNAi in vivo causes a leaky meiotic arrest. Ser15 residue of mWee1B is the major PKA phosphorylation site in vitro, and the inhibitory effects of the kinase are enhanced when this residue is phosphorylated. Thus, mWee1B is a key MPF inhibitory kinase in mouse oocytes, functions downstream of PKA, and is required for maintaining meiotic arrest.
Results and Discussion mWee1b Isolation during a Small-Pool Expression Screening for PKA Substrates
Although PKA involvement in the maintenance of meiotic arrest is widely accepted, it is unclear which PKA substrates are phosphorylated/dephosphorylated during reentry into the cell cycle. To isolate PKA substrates involved in the control of meiotic maturation in mammalian oocytes and to understand the posttranslational steps downstream of PKA, we carried out small-pool expression screening of a mouse oocyte cDNA library (see the Supplemental Experimental Procedures in the Supplemental Data available with this article online). One of the putative PKA substrates isolated by this method codes for a Wee1 kinase homolog (mouse *Correspondence: marco.conti@stanford.edu Wee1B, Figure S1 , Supplemental Data) similar to a previously isolated clone from human cDNA libraries [7] . A mobility shift of this protein was detected when in vitrotranslated [S 35 ]-methionine-labeled mWee1B was incubated with the PKA catalytic subunit ( Figure 1A ). Similar to Xenopus Wee1, which prevents progesterone-induced germinal vesicle breakdown (GVBD) by directly phosphorylating and inhibiting Cdc2 kinase [8, 9] , ectopically expressed mWee1B also prevented Xenopus oocyte GVBD induced by progesterone treatment in a manner dependent on mRNA concentration Figure 1B) . In addition, the Cdc2 inhibitory phosphorylation (phosphotyrosine 15) was not decreased by progesterone treatment when mWee1B mRNA was overexpressed ( Figure 1C) .
To define the role of mWee1B kinase activity in preventing GVBD, we mutated the lysine residue involved in adenosine triphosphate (ATP) binding in several of the known Wee1-family kinases (K237 in Figure S1A ) to methionine [9] , and we injected the mRNA of this mutant into Xenopus oocytes. The inhibitory effect on progesterone-induced Xenopus oocyte maturation could no longer be detected with this kinase-dead mutant ( Figure 1D ). These findings suggest that mWee1B may be involved in the control of meiotic arrest in mammalian oocytes. (Figure 2A ). Mouse Wee1B was detected only in the ovary, whereas Wee1 was expressed predominantly in the thymus, spleen, kidney, and at lower levels in the ovary and other tissues. These findings are consistent with the expression pattern of Xenopus Wee1A kinase, which is present only in the ovary. The cellular patterns of expression of Wee1 and mWee1B mRNAs were further investigated by in situ hybridization. Mouse Wee1B mRNA was detected only in the oocytes at all developmental stages of the follicle including primary, secondary, preantral, and antral follicles with an increase in signal during development (Figures 2B c , 2B d , 2B h , 2B i , and 2B e ). Conversely, Wee1 mRNA was detected only in early developmental stages of oocyte maturation, and oocytes from antral follicles displayed no signal above background (Figures 2B a ,  2B b , 2B f , and 2B g ). Wee1 was also detected in the testis by northern-blot analysis and in situ hybridization, whereas mWee1B was not present (Figure 2A and Figure S2) , unlike that reported in humans, where Wee1B is expressed in the testis [7] . This suggests that mWee1B does not play a role in mouse male meiosis. Conversely, Myt1 mRNA was detected in most tissues including the ovary and the testis, albeit at low levels ( Figure 2A and Figure S3 ). This restricted expression of mWee1B was confirmed by RT-PCR with granulosa cells and oocytes. Mouse Wee1B was detected only in oocytes, whereas Wee1 and Myt1 were present in granulosa cells ( Figure 2C ). Finally, mouse expressed sequence tag (EST) database searches showed that mWee1B sequences are retrieved only in cDNA pools of ovary, GV oocytes, unfertilized eggs, and two-cellstage embryos. All these data strongly suggest that the Wee1B gene is expressed exclusively in oocytes and zygotes.
To determine the expression of mWee1B protein, we produced a mouse Wee1B-specific antibody against the C terminus of the protein ( Figure S1A 
Downregulation of mWee1B by RNAi Induces GVBD in Mouse Oocytes
To probe the function of mWee1B during oocyte maturation, a strategy of RNA interference was used to downregulate mWee1 expression. If mWee1B were to play an essential role in cAMP-mediated meiotic arrest, downregulation of its expression would cause meiotic resumption. A fusion construct of green fluorescence protein (GFP) and hairpin dsRNA corresponding to the amino terminus of the mWee1B sequence was generated [16] . This hairpin construct was injected into eggs to generate transgenic mice, and nine female and two male founders were obtained. Nine founders were used to generate F1 females that were injected with pregnant mare serum gonadotropins (PMSG) at 22-24 days of age. Oocytes were collected in medium supplemented with cilostamide (10 M), and maturation was scored after 24 hr. In oocytes where PDE3A phosphodiesterase is absent or is inhibited with the specific compound, cilostamide, PKA activity is maintained at high levels by the increased cAMP, thus preventing maturation in vitro and in vivo [17] . Under this condition of meiotic block, more than 25% of the oocytes collected from 12 transgenic females from nine founders were no longer in GV and progressed to GVBD or polar-body extrusion ( Figures 3A and 3B which remain arrested in the meiotic prophase even after isolation, approximately 30% resumed meiosis I and extruded a polar body ( Figure S4 ). These data suggest that mWee1B acts downstream of PKA in maintaining the blockade of oocyte maturation. Several contributing factors may explain why downregulation of mWee1B in vitro or in vivo does not produce meiotic maturation in all oocytes. One possibility is that the RNAi produces variable downregulation averaging a 50% reduction in mWee1B mRNA and that the mWee1B protein has a long half-life. Indeed, preliminary observations suggest that mWee1B is more stable than Wee1 when expressed in frog oocytes (S.J.H., unpublished data). Another possibility is that the turnover of Tyr15 phosphorylation is slow in oocytes in the absence of an active Cdc25 phosphatase responsible for dephosphorylation and activation of Cdc2. Thus, a decrease in the activity of the mWee1 kinase is reflected only in a partial decrease in phosphorylation of Cdc2, unless Cdc25 is activated at the same time. Indeed, if PKA phosphorylates Cdc25 and promotes 14-3-3 binding, Cdc25 should be largely inactive in PDE3A −/− oocytes. Finally, it is also possible that a loss of mWee1B activity is compensated by the presence of Wee1 or Myt1 kinase. Wee1 kinase immunoreactivity has been observed in mouse oocytes, even though a decline has been reported in competent oocytes [15] , and Myt1 mRNA is detectable in GV oocytes ( Figure 2C ). Little increase in Myt1 expression was detected in oocytes where mWee1B is downregulated ( Figure 3C ).
Serine 15 of mWee1B Is a Major PKA Phosphorylation
Site, and PKA Phosphorylation Increases mWee1B Kinase Activity Because of its isolation as a putative PKA substrate, we further investigated the possibility that PKA can directly Figure 4A, lane 4) . However, when a kinase-dead mutant of mWee1B was used, the autophosphorylation was abolished, but the PKA phosphorylation was still evident (Figure 4A) . Because a major difference in [ 32 P] incorporation was observed between kinase-dead and wild-type mWee1B, we hypothesized that PKA phosphorylation enhances the autophosphorylation of mWee1B. Indeed, when a phosphotyrosinespecific antibody was used, an increase in mWee1B tyrosine phosphorylation was observed in wild-type mWee1B but not in the kinase-dead mutant ( Figure  4A, middle panel) Figure 4B ) indicated that the N terminus of mWee1B contains the major PKA phosphorylation site(s). Although two putative PKA consensus sequences at S15 and T170 were identified, S15 is likely the major phosphorylation site because the 124-546 fusion protein is not phosphorylated by PKA.
Even though it is distinct from the known consensus 14-3-3 binding sequence (RSXS) found in Xenopus and mammalian Wee1, mWee1B displays a related sequence at the C terminus (RGTSSV, Figure S1A ), opening the possibility of a PKA phosphorylation that is at the carboxyl terminus and promotes 14-3-3 binding. Indeed, some minor PKA phosphorylation could be detected with the C terminus of mWee1B ( Figure 4B, 479-556 ). This phosphorylation was not explored further because we could not detect coimmunoprecipitation of 14-3-3 protein with unphosphorylated or phosphorylated mWee1B when overexpressed in HEK293 cells (data not shown). To confirm whether S15 is the major PKA phosphorylation site, we generated GST-mWee1B fusion proteins containing only the N terminus of mWee1B with point mutations in the putative PKA phosphorylation sites, and we performed an in vitro phosphorylation ( Figure 4C) . A major decrease in [ 32 P] incorporation was observed after the mutation of S15 to alanine. A similar result was obtained with a S15A mutant of full-length mWee1B ( Figure 4D) .
The functional consequence of the phosphorylation of S15 was determined by mRNA injection of the phosphorylation mutants of mWee1B in frog oocytes. When the mRNA of the S15D mutant that mimics the phosphorylation state was injected into Xenopus oocytes, this mutant inhibited progesterone-induced maturation more efficiently than wild-type mWee1B ( Figure 4E) . The 15D mutant-enhanced inhibition of oocyte GVBD is due to direct phosphorylation and inhibition of Cdc2 kinase (data not shown). Conversely, inhibition by the S15A mutant did not differ from that of wild-type mWee1B, possibly because progesterone treatment causes a decrease in PKA activity. That mWee1B activity is increased after S15 phosphorylation was further demonstrated with a reconstitution assay. Histone H1 phosphorylation by MII oocyte extracts was determined after incubation with different mWee1B constructs. MII extracts contained dephosphorylated and therefore activated Cdc2/cyclinB complex, which phosphorylates histone H1. The S15D mutant inhibited H1 phosphorylation more potently than wild-type mWee1B ( Figure 4F) . These results strongly suggest that PKA phosphorylates S15 of mWee1B, and this phosphorylation causes an increase in mWee1 activity toward Cdc2/cyclinB with consequent enhanced inhibitory effects on oocyte maturation. PKA activation of Wee1B was difficult to detect in this assay paradigm because PKA directly phosphorylates histone H1 and increases the background (data not shown).
The most straightforward hypothesis on how cAMP inhibits the MPF activity is that PKA directly phosphorylates and regulates the Cdc25 phosphatase and Wee1/Myt1 kinase. In agreement with this view, it has been reported that PKA phosphorylates and inhibits the function of Cdc25 through 14-3-3 binding in frog oocytes [19] , even though the timing of this phosphorylation is inconsistent with a decrease in PKA activity. Here, we show that mWee1B is a substrate for PKA in vitro and have identified the major phosphorylation site in S15; the site lies within a consensus sequence for PKA (KKLS). This region is conserved only partially when human and frog sequences are compared. Rather than the PKA consensus, a related sequence is present in human and frog Wee1 orthologs and includes a positively charged R or K upstream of an S. Further experiments are necessary to determine when dephosphorylation of mWee1B occurs and whether the regulation observed in the mouse can be extended to other species. There is precedence for Wee1 activation by phosphorylation. MAP kinase activates XeWee1A via phosphorylation during the first mitotic cell cycle, producing a delay in G2/M [20] . However, the phosphorylation sites and exact mechanisms leading to an increase in the Wee1 kinase activity have not been elucidated. XeWee1A also is positively regulated by Chk1-kinase-dependent phosphorylation on the C terminus of XeWee1 [21] . Thus, in addition to phosphorylations that promote targeting to the proteasome and Wee1 degradation [22] , there is an additional mode of Wee1-kinase regulation controlling its activation. It is likely that multiple phosphorylations are required for fine regulation of the function of this kinase that is essential for G2/M transition.
Conclusions
With this report, we demonstrate that mWee1B is a maternally-expressed kinase involved in the phosphorylation of Cdc2 and maintenance of meiotic arrest in oocytes. Mouse Wee1B is exclusively expressed in maturing oocytes, and downregulation of this mRNA causes meiotic resumption under conditions that normally maintain meiotic arrest. Conversely, overexpression of mWee1B delays meiotic maturation in Xenopus oocytes, and its kinase activity is required for this inhibition. PKA directly phosphorylates mWee1B in a concentration-dependent manner, at least in vitro. Serine 15 in the N terminus of mWee1B is a major PKA phosphorylation site, and phosphorylation at this site enhances the autophosphorylation activity of mWee1B and its ability to inhibit Cdc2 and oocyte maturation. Thus, mWee1B is likely to be a key regulator of meiotic maturation in mouse oocytes. In view of the expression of mWee1B during MII, further experiments are necessary to explore its function during the first embryonic divisions. These findings solidify the concept that PKA maintains meiotic arrest via dual regulation of the kinase that phosphorylates Cdc2 and the phosphatase that dephosphorylates the same sites. The two limbs of the regulatory loop most likely work in a synergistic fashion to maintain an inactive Cdc2/cyclinB complex. 
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